Venlafaxine ER capsules are indicated for the treatment of major depressive disorder, generalised anxiety disorder, social anxiety disorder and panic disorder (Source: Zydus Lifesciences website) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Zydus Lifesciences on Tuesday said it has received approval from the Chinese health regulator to market a medication for the treatment of major depressive disorder among others.

The company has received approval from the National Medical Products Administration (NMPA), China for Venlafaxine extended-release capsules in strengths of 75 mg and 150 mg respectively, the drug firm said in a statement.

Venlafaxine ER capsules are indicated for the treatment of major depressive disorder, generalised anxiety disorder, social anxiety disord

See Full Page